Literature DB >> 26495112

Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii.

Zahra Zanganeh1, Fereshteh Eftekhar1.   

Abstract

BACKGROUND: Emergence of multidrug-resistant Acinetobacter baumannii has resulted in the treatment failure of related infections and an increase in patient mortality. The presence of class D β-lactamases (oxacillinases) in this organism is an important mechanism underlying resistance to beta-lactam antibiotics.
OBJECTIVES: The aim of this work was to investigate the correlation between oxacillinase gene carriage and genetic fingerprints in imipenem-resistant burn and non-burn isolates of A. baumannii.
MATERIALS AND METHODS: Fifty-eight A. baumannii isolates were collected from October 2011 to April 2012, which included 28 burn isolates from Shahid Motahari Hospital and 30 non-burn isolates from Imam Hossein Hospital. The minimum inhibitory and minimum bactericidal concentrations (MIC and MBC) of imipenem were measured by the broth microdilution method. The presence of oxacillinase genes (OXA-23-, OXA-24-, OXA-51-, and OXA-58-like genes) was shown using type-specific primers and PCR. Genetic profiles were generated by RAPD-PCR fingerprinting.
RESULTS: OXA-23 was observed in 81% of the isolates and its distribution was similar within the two groups. The presence of OXA-51 was shown in 58.6% of the isolates, of which most were burn isolates (67.6%). OXA-24 was present in 20.7% of the isolates, all belonging to the burn group; OXA-58 was not observed in any of the isolates. RAPD-PCR fingerprints revealed two clusters at a similarity level of 70% (A, B). At a similarity level of 85%, nine different groups were observed for burn and non-bun isolates.
CONCLUSIONS: Our results showed that bla OXA-23 was the most prevalent gene, followed by bla OXA-51 , among the burn and non-burn clinical isolates of A. baumannii. Bla OXA-24 -like genes were detected at a lower level and were only found among the burn isolates, which also showed higher heterogeneity compared to the non-burn group.

Entities:  

Keywords:  Acinetobacter baumannii; PCR, RAPD-PCR

Year:  2015        PMID: 26495112      PMCID: PMC4609178          DOI: 10.5812/jjm.26545

Source DB:  PubMed          Journal:  Jundishapur J Microbiol        ISSN: 2008-3645            Impact factor:   0.747


1. Background

Emergence and spread of multidrug-resistant (MDR) Acinetobacter baumannii in nosocomial settings has become a serious concern in clinical practice. The organism commonly targets critically ill patients in intensive care units (ICU) and burn wards (1). The infections caused by this organism include bacteremia, ventilator-associated pneumonia, meningitis, and infections of the urinary tract, wounds, and burns (1, 2). Acinetobacter baumannii exhibits a variety of resistance mechanisms to all existing antibiotic classes, including active drug efflux, modification of drug target sites, and most importantly, enzymatic inactivation of the antimicrobial agents (2, 3). Carbapenems, especially imipenem, is often used as the drug of choice for treatment of A. baumannii infections. However recently, high levels of resistance have emerged, causing treatment failure (4, 5). The most common mechanism responsible for carbapenem resistance in A. baumannii is production of carbapenemases, including metallo-β-lactamases (MBLs) and class D β-lactamases (oxacillinases) which, class D β-lactamases have been reported as the most widespread carbapenemases in A. baumannii isolates (2, 5-8). The first oxacillinase found in A. baumannii was observed in an imipenem-resistant strain in Scotland in 1985, which was later designated as OXA-23. Today, over 220 OXA-type enzymes have been reported (9). Among these, five main phylogenetic subgroups have been recognized in imipenem-resistant A. baumannii, including OXA-23-, OXA-24/40-, OXA-51-, OXA-58-, and more recently, OXA-143-like oxacillinases (10). The largest subgroup is the chromosomally encoded OXA-51, followed by OXA-23-like enzymes (10, 11). However, plasmid-mediated OXA-51 genes have also been reported (12). bla- and bla-like genes can be chromosomal or plasmid-mediated, whereas bla-like genes are mostly plasmid-mediated (11). Rapid development of MDR strains, mostly owing to the horizontal transfer of antibiotic determinants among the isolates, makes it imperative to identify the underlying resistance mechanisms and study the epidemiology of these infections. Among the fingerprinting methods used, randomly amplified polymorphic DNA (RAPD) has been widely used to detect polymorphisms in many organisms, including A. baumannii.

2. Objectives

The objective of this study was to compare the presence of bla-, bla-, bla-, and bla-like genes in two groups of burn and non-burn clinical isolates of A. baumannii and study the clonal spread and heterogeneity of the isolates.

3. Materials and Methods

3.1. Bacterial Isolates

Fifty-eight A. baumannii isolates were collected from Imam Hossein (30 non-burn) and Shahid Motahari (28 burn) Hospitals from October 2011 to April 2012 in Tehran. Table 1 shows the distribution of different specimen types among burn and non-burn clinical isolates of A. baumannii. Phenotypic identification of the isolates was confirmed by standard biochemical tests; the isolates were maintained in brain heart infusion broth (Oxoid, UK) containing 10% dimethyl sulfoxide (v/v) at -20°C.
Table 1.

Distribution of Different Specimen Types among Burn and Non-Burn Clinical Isolates of Acinetobacter baumannii [a]

Isolate GroupNumber of Isolates in Each Specimen Type
WoundSputumBloodCatheterCSFTrachea
Burn 2530000
Non-burn 3165321

a Abbreviation: CSF, cerebral spinal fluid.

a Abbreviation: CSF, cerebral spinal fluid.

3.2. Imipenem Susceptibility Testing

The MIC and MBC of imipenem (Moon Chemicals, China) were determined by broth microdilution, according to the guidelines recommended by the Clinical and Laboratory Standards Institute (13).

3.3. Detection of OXA-Like Genes by PCR

DNA extraction was carried out by boiling. Briefly, a loopful of an overnight grown culture of each test isolate was suspended in 500 μL of sterile double-distilled water, boiled at 100°C for 10 min, and centrifuged at 13,000 × g for 10 minutes. The supernatant was then used as the DNA template for PCR amplification. bla-, bla-, bla-, and bla-like genes were detected by PCR using the primers listed in Table 2 (14). PCR reaction mixtures (25 μL) contained 1 μL of DNA template, 1.4 mM MgCl2, 0.2 mM each dNTP, 0.4 μM primer, and 0.625 U of Taq DNA polymerase in the buffer provided by the manufacturer (CinnaGen, Iran). The amplifications were performed in a thermocycler (Techne TC-3000G; UK), with the following program: initial denaturation at 94°C for 5 minutes, 33 cycles of 94°C for 25 seconds, 53°C for 40 seconds, and 72°C for 50 seconds, followed by a final elongation step at 72°C for 6 minutes (11). A. baumannii NCTC 13304 harboring bla and A. baumannii NCTC 12156 carrying bla were used as controls (15). PCR products were separated on 1% agarose gels and observed after staining with RedSafe (iNtRON Biotechnology, Korea) using an image analysis system (UVLtec; St John's Innovation Centre, UK).
Table 2.

Primers Used for Detection of OXA-Like Genes

PrimerSequenceProduct Size, bp
OXA-23 501
Forward5´-GATCGGATTGGAGAACCAGA-3´
Reverse5´-ATTTCTGACCGCATTTCCAT-3´
OXA-24 246
Forward5´-GGTTAGTTGGCCCCCTTAAA-3´
Reverse5´-AGTTGAGCGAAAAGGGGATT-3´
OXA-51 353
Forward5´-TAATGCTTTGATCGGCCTTG-3´
Reverse5´-TGGATTGCACTTCATCTTGG-3´
OXA-58 599
Forward5´-AAGTATTGGGGCTTGTGCTG-3´
Reverse5´-CCCCTCTGCGCTCTACATAC-3´

3.4. Generation of DNA Fingerprints by RAPD-PCR

PCR reaction mixtures (25 μL) contained 2 μL of template DNA, 0.5 mM each dNTP, 4 mM MgCl2, 1.5 U of Taq polymerase, and 1 μM DAF4 primer (5´-CGGCAGCGCC-3´) in the buffer provided by the manufacturer (CinnaGen, Iran) (16). Amplifications were performed in a thermal cycler (Techne TC-3000G, UK) using the following program: denaturation at 94°C for 2 minutes followed by 45 cycles of denaturation at 94°C for 40 seconds, annealing at 48°C for 1 minute, and extension at 72°C for 40 seconds, with a final extension period of 5 minutes at 72°C. The PCR products were separated on 1.2% agarose gels, stained, and visualized as described above.

3.5. Statistical Analyses

Chi-square analysis was employed for the comparison of OXA gene carriage between the two groups of isolates using the SPSS version 21. Dendrograms for RAPD fingerprints were generated based on the band-matching coefficient of Dice, SAHN, and clustering in the unweighted pair group method with arithmetic averages (NTSYS-pc version 2.02; Exeter Software, Setauket, NY, USA).

4. Results

All isolates were resistant to imipenem with MIC and MBC values of > 32 μg/mL. However, these values for non-burn isolates ranged from 32 to 128 μg/mL, whereas the burn isolates had MIC and MBC values of > 128 – 1012 μg/mL, indicating even higher levels of resistance. The results of PCR amplifications (Figure 1) showed that bla was present in 47 isolates (81%), which was not significantly different between the two groups (78.6% burn vs. 83.3% non-burn). The presence of bla was shown in 34 isolates (58.6%), of which most were burn isolates (82.1% vs. 36.6%, P < 0.05). Interestingly, bla was found in 12 isolates (20.7%), all belonging to the burn group, and none of the isolates harbored bla (Figure 1). Overall, among the non-burn group, 16 isolates (53.3%) carried bla and two (6.7%) harbored bla alone, nine (30%) had both genes, and three did not carry any of the tested OXA genes. On the other hand, OXA-like genes were more widely distributed among the burn isolates, where one (3.6%), two (7.2%), and three (10.6%) isolates carried bla, bla, and bla alone, respectively. Twelve burn strains had both bla and bla (42.8%), two carried bla/bla (7.2%), one harbored bla/bla (3.6%), and seven isolates had all three OXA-like genes (25%). These results show a higher rate of multiple OXA gene carriage among the burn isolates and correlate with the higher imipenem MIC and MBC values obtained for the burn isolates.
Figure 1.

Distribution of Oxacillinase Genes in Imipenem-Resistant Burn and Non-Burn Isolates of Acinetobacter baumannii

Figure 2 presents the RAPD fingerprints of A. baumannii isolates. Analysis of these fingerprints revealed two clusters (A and B) at a similarity level of 70% and nine groups at a similarity level of 85% (Figure 3). Table 3 shows the distribution of RAPD fingerprints among burn and non-burn isolates. Most of the burn isolates (n = 18, 64.3%) were placed in cluster B, of which, seven, eight, and three belonged to the groups B7, B8, and B9, respectively. Of the 10 burn isolates in cluster A, four, five, and one isolate were placed in the groups A3, A4, and A5, respectively (Table 3). Most of the non-burn strains belonged to cluster A (n = 21, 70%), of which majority (n = 16, 76.2%) were in the group A1 and the remaining five were found in groups A2 (n = 1), A3 and A4 (n = 2 each). The non-burn strains placed in cluster B were found in groups B6 and B7 (n = 4 each), and B8 (n = 1). These results suggest the clonal spread of A. baumannii in the clinical isolates from the two hospitals. However, a higher degree of heterogeneity was observed among the burn isolates compared to the non-burn isolates.
Figure 2.

RAPD-PCR Finger Prints of Acinetobacter baumannii Clinical Isolates

M, 100-bp DNA molecular weight marker, profiles 37 - 42 show the DNA fingerprints of non-burn isolates; 43 - 51 represent the DNA profiles of burn isolates.

Figure 3.

Clonal Distribution of Acinetobacter baumannii Burn and Non-Burn Isolates Using RAPD-PCR Fingerprints at a Similarity Level of 85%

A dendrogram was generated based on the band-matching coefficient of Dice, SAHN, and clustering in the unweighted pair group method with arithmetic averages.

Table 3.

Distribution of RAPD-PCR Fingerprints among Burn and Non-Burn Cluster B (No. of Isolates)

Isolate GroupCluster A (No. of Isolates)Cluster B (No. of Isolates)
70% [a]85% [a]70% [a]85% [a]
A1A2A3A4A5B6B7B8B9
Burn 10--45118-783
Non-Burn 21161622-944-1

a level of similarity.

RAPD-PCR Finger Prints of Acinetobacter baumannii Clinical Isolates

M, 100-bp DNA molecular weight marker, profiles 37 - 42 show the DNA fingerprints of non-burn isolates; 43 - 51 represent the DNA profiles of burn isolates.

Clonal Distribution of Acinetobacter baumannii Burn and Non-Burn Isolates Using RAPD-PCR Fingerprints at a Similarity Level of 85%

A dendrogram was generated based on the band-matching coefficient of Dice, SAHN, and clustering in the unweighted pair group method with arithmetic averages. a level of similarity.

5. Discussion

Nosocomial outbreaks of oxacillinase-producing A. baumannii have been reported worldwide. Among the five main phylogenic subgroups, the chromosomally located blaOXA-51-like gene has been used as a species-specific marker for the identification of A. baumannii (16-18). However, plasmid-mediated OXA-51 has also been detected in A. baumannii isolates (12). In addition, “non-baumannii” species of Acinetobacter have been shown to harbor bla (19). In the present study, 58.6% of the A. baumannii clinical isolates harbored bla, majority of which were burn isolates. The prevalence of bla in the clinical isolates of A. baumannii was reported as 77.8% in Turkey and 85.3% in South Africa (20, 21). Iranian studies have mostly used the presence of bla as a tool to identify A. baumannii and have shown 100% carriage of the gene (18, 22, 23). The presence of bla does not correlate with the level of carbapenem resistance because the gene is regulated by the insertion sequence ISAba1; this indicates that resistance to carbapenems cannot be inferred solely from the detection of bla-like genes (24). In contrast, genes encoding OXA-23, OXA-24, and OXA-58 enzymes are consistently associated with resistance or reduced susceptibility to imipenem (24). Among oxacillinases, OXA-23 has been shown as the most prevalent gene in Acinetobacter spp. worldwide, followed by bla (11, 25, 26). As found in the present study, several studies from Iran have found bla to be the most prevalent oxacillinase gene, and found much lower rates of bla and bla occurrence among A. baumannii clinical isolates (18, 23, 27). Coexistence of multiple OXA genes has been reported in many studies. Feizabadi et al. showed that 25% and 17.9% of MDR A. baumannii carried bla/bla and bla/bla, respectively (18). A study from Poland compared OXA gene carriage between burn and ICU isolates and found that bla/bla genes were dominant in the ICU group and bla/bla-like genes were dominant among the burn isolates (28). Our results showed that only 30% of the non-burn isolates carried bla/bla, while 78.6% of the burn isolates harbored two to three oxacillinase genes. Our RAPD-PCR results showed clear differences between the distribution of OXA genes in the two groups of isolates; higher heterogeneity was observed among the burn strains (Table 2). Sadeghifard et al. showed 6 RAPD-PCR patterns among Acinetobacter spp. isolates in Tehran and found distinguishable fingerprints for A. baumannii strains compared to the non-A. baumannii isolates (29). Popova et al. used RAPD-PCR to type 130 MDR A. baumannii strains and showed that all strains grouped into two clusters (A and B), of which 82% were in the two dominant groups (30). We also found two clusters among which the RAPD fingerprints of both groups of isolates were distributed. However, most of the burn isolates (64.3%) were placed in one cluster (B). Conversely, 70% of the non-burn isolates were placed in the second cluster (A). In addition, there was much higher heterogeneity among the burn isolates at a similarity level of 85%, compared to that among the non-burn isolates (Table 2). These results show the limited lineage of infection-causing A. baumannii isolates in hospital environments. The heterogeneity, when detected, would most probably be attributed to the horizontal transfer of genetic elements such as plasmids among individual isolates.
  25 in total

1.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Association between β-lactamase-encoding bla(OXA-51) variants and DiversiLab rep-PCR-based typing of Acinetobacter baumannii isolates.

Authors:  Esther Zander; Alexandr Nemec; Harald Seifert; Paul G Higgins
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

3.  OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.

Authors:  S M Amudhan; U Sekar; K Arunagiri; B Sekar
Journal:  Indian J Med Microbiol       Date:  2011 Jul-Sep       Impact factor: 0.985

Review 4.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

5.  Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy.

Authors:  Silvia D'Arezzo; Luigi Principe; Alessandro Capone; Nicola Petrosillo; Andrea Petrucca; Paolo Visca
Journal:  J Antimicrob Chemother       Date:  2010-11-18       Impact factor: 5.790

6.  Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp.

Authors:  H J Grundmann; K J Towner; L Dijkshoorn; P Gerner-Smidt; M Maher; H Seifert; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  [Molecular characterization of the multidrug-resistant Acinetobacter baumannii strains and assessment of their sensitivity to the phage AP22].

Authors:  A V Popova; V P Miakinina; M E Platonov; N V Volozhantsev
Journal:  Mol Gen Mikrobiol Virusol       Date:  2012

8.  Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.

Authors:  Karyne Rangel Carvalho; Ana Paula D'Alincourt Carvalho-Assef; Gisele Peirano; Lia Cristina Galvão Dos Santos; Maria José Felix Pereira; Marise Dutra Asensi
Journal:  Int J Antimicrob Agents       Date:  2009-02-11       Impact factor: 5.283

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

View more
  2 in total

Review 1.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

2.  Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of bla OXA-24-like and bla OXA-58-like genes.

Authors:  Niloofar Tafreshi; Laleh Babaeekhou; Maryam Ghane
Journal:  Iran J Microbiol       Date:  2019-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.